Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 541 for “"pharmacodynamic"”.

  1. Pharmacokinetic and pharmacodynamic studies on flaxseed lignans

    … cancer. The pharmacokinetic characteristics and pharmacodynamics properties of flaxseed lignans warrant their further investigation.

    sask Repository record for Pharmacokinetic and pharmacodynamic studies on flaxseed lignans (opens in a new tab)

  2. Modelling choices in pharmacokinetic and pharmacodynamic models

    Pharmacokinetic and pharmacodynamic (PKPD) models can be used to predict the benefits or toxicity from drugs, such as the neutropaenia, anaemia and thrombocytopaenia caused by chemo-therapeutic drugs. In this thesis, I will be exploring the methodology used to make modelling decisions in these PKPD …

    oxford Repository record for Modelling choices in pharmacokinetic and pharmacodynamic models (opens in a new tab)

  3. Novel approaches to mechanistic pharmacokinetic/pharmacodynamic modeling

    … discovery and development, pharmacokinetic and pharmacodynamic modeling are successfully applied to analyze and predict the time course of drug concentration and drug effect in the patient. Empirical compartment models and physiology-based pharmacokinetic (PBPK) models are routinely employed to …

    fu-berlin Repository record for Novel approaches to mechanistic pharmacokinetic/pharmacodynamic modeling (opens in a new tab)

  4. Pharmacokinetic/pharmacodynamic modeling can guide drug candidate optimization

    … properties. We aim to use pharmacokinetic/pharmacodynamics (PK/PD) modelling to prioritize alterations in drug properties such as potency, clearance, and free drug concentrations in order to reduce the predicted efficacious dose. We have used simple differential equations and simulation …

    ubc Repository record for Pharmacokinetic/pharmacodynamic modeling can guide drug candidate optimization (opens in a new tab) Download PDF for Pharmacokinetic/pharmacodynamic modeling can guide drug candidate optimization (opens in a new tab)

  5. Pharmacodynamic Responses And Efficacies Associated With Lrrk2 Inhibition

    … with animal models of disease to characterize pharmacodynamic markers of LRRK2 kinase inhibition, test efficacy for neuroprotection, and evaluate LRRK2 target engagement biomarkers in biofluids as a means to predict potential outcomes and pitfalls in early phase clinical trials of …

    uab Repository record for Pharmacodynamic Responses And Efficacies Associated With Lrrk2 Inhibition (opens in a new tab)

  6. Canine pharmacodynamic assays: applications in immune-mediated disease

    … the need for optimization of drug dosing. Pharmacodynamic assays are utilized in human medicine to evaluate the efficacy of immunosuppressive therapy in individual patients. The purpose of this Master's project was to validate an in vitro flow-cytometric assay evaluating canine B and T …

    missouri Repository record for Canine pharmacodynamic assays: applications in immune-mediated disease (opens in a new tab)

  7. Single Cell Pharmacodynamic Modeling of Cancer Cell Lines

    Cancer is one of the leading causes of disease related death worldwide. Since the discovery of the genomic origins of cancer, targeted therapy has been developed towards specific mutations implicated for oncogenic transformation. However, current standard-of-care for mapping cancer patients to …

    clemson Repository record for Single Cell Pharmacodynamic Modeling of Cancer Cell Lines (opens in a new tab)

  8. Determinants of Pharmacodynamic Heterogeneity in Multiple Myeloma Cells

    Multiple myeloma is a complex heterogeneous hematological malignancy comprising of rapidly proliferating genetically diverse clonal plasma cells. Tumor initiation, development, and progression occur through a series of pre-malignant stages, with sequential acquisition of genomic aberrations. The …

    buffalo Repository record for Determinants of Pharmacodynamic Heterogeneity in Multiple Myeloma Cells (opens in a new tab)

  9. Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models

    Systemic Lupus Erythematosus (SLE), is a chronic autoimmune disease that can affectmultiple organ systems. Survival rates have improved in recent years but SLE is stillcurrently “managed” rather than “cured” and traditional treatments can cause irreversibledamage, sometimes leading to death. …

    strathclyde Repository record for Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models (opens in a new tab)

  10. Pharmacodynamics miner : an automated extraction of pharmacodynamic drug interactions

    Pharmacodynamics (PD) studies the relationship between drug concentration and drug effect on target sites. This field has recently gained attention as studies involving PD Drug-Drug interactions (DDI) assure discovery of multi-targeted drug agents and novel efficacious drug combinations. A PD drug …

    iupui Repository record for Pharmacodynamics miner : an automated extraction of pharmacodynamic drug interactions (opens in a new tab)

  11. Pharmacokinetic and Pharmacodynamic Modelling to Advance Perioperative Anaesthesia and Analgesia

    … and alongside others. Pharmacokinetic (PK) and pharmacodynamic (PD) models summarise complex drug relationships so they may be better understood and capitalised on. I report my investigations into using PKPD models to describe combined drug responses for applications in anaesthesia. I …

    auckland-ms Repository record for Pharmacokinetic and Pharmacodynamic Modelling to Advance Perioperative Anaesthesia and Analgesia (opens in a new tab)

  12. The role of population pharmacokinetic-pharmacodynamic modelling in antimalarial chemotherapy

    … antimalarials. Using pharmacokinetic and pharmacodynamic data from field trials where mefloquine was administered either alone or in combination with artesunate important information regarding optimal dosing for the clinician has been obtained. The pharmacokinetics of mefloquine were …

    the-open-u Download PDF for The role of population pharmacokinetic-pharmacodynamic modelling in antimalarial chemotherapy (opens in a new tab)

  13. Immulina® As an Immunostimulatory Supplement: Dissolution and Pharmacodynamic Studies

    As one of popular dietary supplements, the health benefits of Arthrospira platensis (commonly known as spirulina) have been broadly reported. Immulina is a commercially available extract of Arthrospira platensis that is enriched with bacterial lipoproteins and acts as a Toll-like receptor 2 (TLR2) …

    mississippi Repository record for Immulina® As an Immunostimulatory Supplement: Dissolution and Pharmacodynamic Studies (opens in a new tab)

  14. Pharmacokinetic and pharmacodynamic studies of mycophenolic acid in renal transplant recipients

    … purpose was to identify the pharmacokinetic and pharmacodynamic profiles, to establish the PK-PD relationship of MPA and to quantify average population pharmacokinetic and pharmacodynamic parameters and evaluate the influence covariates on the PK-PD variability.Stable renal transplant patients …

    nus Repository record for Pharmacokinetic and pharmacodynamic studies of mycophenolic acid in renal transplant recipients (opens in a new tab) Download file for Pharmacokinetic and pharmacodynamic studies of mycophenolic acid in renal transplant recipients (opens in a new tab)

  15. Population Pharmacokinetic Pharmacodynamic Modelling to Improve Anaesthesia in Children and Adults

    Pharmacokinetic pharmacodynamic models are used in adult and paediatric anaesthesia. The pharmacokinetic parameter volume is used to calculate loading dose while maintenance dose rates can be determined from clearance. The major differences (covariates) between children and adults concern growth …

    auckland-ms Repository record for Population Pharmacokinetic Pharmacodynamic Modelling to Improve Anaesthesia in Children and Adults (opens in a new tab)

  16. Improving antifungal use in the critically ill: a pharmacokinetic/pharmacodynamic approach

    The overall aim of the thesis is to investigate the PK of antifungal agents in ICU patients.This thesis involved studies conducted in patients with sepsis/septic shock with organ dysfunction including patients with renal dysfunction requiring SLED-f.

    adelaide Repository record for Improving antifungal use in the critically ill: a pharmacokinetic/pharmacodynamic approach (opens in a new tab)

  17. Improving hematopoietic cell transplantation therapeutics:emphasis in pharmacokinetic-pharmacodynamic relationships and pharmacogenomics.

    … will be focused on defining pharmacokinetic-pharmacodynamic relationships, and pharmacogenomics involving two antineoplastic agents, fludarabine and clofarabine, and the immunosuppressive agent, mycophenolate all of which are used in the setting of HCT. Fludarabine is a purine analog commonly …

    umn Repository record for Improving hematopoietic cell transplantation therapeutics:emphasis in pharmacokinetic-pharmacodynamic relationships and pharmacogenomics. (opens in a new tab)

  18. Nonparametric Bayes approach for a semi-mechanistic pharmacokinetic and pharmacodynamic model

    … to characterize population pharmacokinetics and pharmacodynamics(PK/PD) models. These methods focus on estimating the population parameters and assessing the association between the characteristics of PK/PD and the subject covariates. In this work, we propose a Dirichlet process mixture model to …

    unm Repository record for Nonparametric Bayes approach for a semi-mechanistic pharmacokinetic and pharmacodynamic model (opens in a new tab)

Page 1 of 28